Exact Mass: 602.1633

Exact Mass Matches: 602.1633

Found 89 metabolites which its exact mass value is equals to given mass value 602.1633, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Amaroswerin

[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

C29H30O14 (602.1635)


Amaroswerin is a member of biphenyls. Amaroswerin is a natural product found in Swertia japonica, Gentianella nitida, and other organisms with data available. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1]. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1].

   

10-Formyl-THF-L-glutamate

2-[[4-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl)methyl-formylamino]benzoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid

C25H30N8O10 (602.2085)


   

Eriodictyol 7-(6-galloylglucoside)

(6-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3,4,5-trihydroxybenzoic acid

C28H26O15 (602.1272)


Eriodictyol 7-(6-galloylglucoside) is found in fruits. Eriodictyol 7-(6-galloylglucoside) is a constituent of the leaves and branches of Phyllanthus emblica (emblic). Constituent of the leaves and branches of Phyllanthus emblica (emblic). Eriodictyol 7-(6-galloylglucoside) is found in fruits.

   

Tipranavir

N-{3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3,4-dihydro-2H-pyran-5-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulphonamide

C31H33F3N2O5S (602.2062)


Tipranavir is only found in individuals that have used or taken this drug. It is a sulfonamide-containing dyhydropyrone and a nonpeptidic protease inhibitor that targets the HIV protease. It is administered with ritonavir in combination therapy to treat HIV infections.Tipranavir inhibits the processing of the viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions. Two mechanisms are suggested in regards to the potency of tipranavir: 1. Tipravanir may bind to the active site of the protease enzyme with fewer hydrogen bonds than peptidic protease inhibitors, which results in increased flexibility, allowing it to fit into the active site of the enzyme in viruses that have become resistance to other protease inhibitors. This also enables tipranavir to adjust to amino acid substitutions at the active site. 2. Tipranavirs strong hydrogen bonding interaction with the amide backbone of the protease active site Asp30 may lead to its activity against resistant viruses.

   

N-[3-[(1S)-1-[(6R)-2,4-Dioxo-6-(2-phenylethyl)-6-propyloxan-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide

N-[3-[(1S)-1-[(6R)-2,4-Dioxo-6-(2-phenylethyl)-6-propyloxan-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulphonamide

C31H33F3N2O5S (602.2062)


   

Epipodophyllotoxin derivitive

16-({7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl}oxy)-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1,3(7),8-trien-12-one

C30H34O13 (602.1999)


   

QUINOLONE DERIVATIVE

7-{4-[2-(4-chlorophenyl)-2-({[hydroxy(pyridin-4-yl)methylidene]amino}imino)ethyl]piperazin-1-yl}-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate

C31H28ClFN6O4 (602.1844)


   

Dahuribirin C

Dahuribirin C

C33H30O11 (602.1788)


   
   

CHEMBL1834753

CHEMBL1834753

C32H26O12 (602.1424)


   

(2S)-5,7,3,4-Tetrahydroxyflavanone 7-(6-galloylglucoside)

(2S)-5,7,3,4-Tetrahydroxyflavanone 7-(6-galloylglucoside)

C28H26O15 (602.1272)


   

Dahuribirin F

Dahuribirin F

C33H30O11 (602.1788)


   

2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-

2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-

C31H33F3N2O5S (602.2062)


   

Lactranthospiren (?)

Lactranthospiren (?)

C39H22O7 (602.1365)


   

(-)-epicatechin 3-O-beta-D-(3-O-vanillil)allopyranoside

(-)-epicatechin 3-O-beta-D-(3-O-vanillil)allopyranoside

C29H30O14 (602.1635)


   

lissoclibadin 2

lissoclibadin 2

C26H38N2O4S5 (602.1435)


An organosulfur heterocyclic compound isolated from the ascidian Lissoclinum badium. It has been shown to exhibit cytotoxicity against human cancer cell lines.

   
   

6-O-p-Hydroxybenzoylcatalposide

6-O-p-Hydroxybenzoylcatalposide

C29H30O14 (602.1635)


   

3-hydroxy-4-O-beta-D-(6-O-vanilloylglucopyranosyl)benzyl vanilloate|litseaefoloside D

3-hydroxy-4-O-beta-D-(6-O-vanilloylglucopyranosyl)benzyl vanilloate|litseaefoloside D

C29H30O14 (602.1635)


   

(-)-epicatechin 3-O-beta-D-(2-O-vanillyl)allopyranoside

(-)-epicatechin 3-O-beta-D-(2-O-vanillyl)allopyranoside

C29H30O14 (602.1635)


   

3,5-dicaffeoyl-4-malonylquinic acid

3,5-dicaffeoyl-4-malonylquinic acid

C28H26O15 (602.1272)


   
   

(S)-5,7,3,5-tetrahydroxyflavanone-7-O-(6-galloyl)-beta-D-glucopyranose

(S)-5,7,3,5-tetrahydroxyflavanone-7-O-(6-galloyl)-beta-D-glucopyranose

C28H26O15 (602.1272)


   

1,2-dicaffeoyl-6-tuliposide A|1,2-O-dicaffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose

1,2-dicaffeoyl-6-tuliposide A|1,2-O-dicaffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose

C29H30O14 (602.1635)


   

1,4-dicaffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-caffeoyloxy-2-methylenebutyroyl)-beta-D-glucopyranose

1,4-dicaffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-caffeoyloxy-2-methylenebutyroyl)-beta-D-glucopyranose

C29H30O14 (602.1635)


   

alterporriol F

alterporriol F

C32H26O12 (602.1424)


   

1-methoxyoxalyl-3,5-dicaffeoylquinic acid|1-MO-3,5-DCQA|1-O-methoxyoxaloyl-3,5-di-O-caffeoylquinic acid

1-methoxyoxalyl-3,5-dicaffeoylquinic acid|1-MO-3,5-DCQA|1-O-methoxyoxaloyl-3,5-di-O-caffeoylquinic acid

C28H26O15 (602.1272)


   

dermocanarin 9

dermocanarin 9

C33H30O11 (602.1788)


   

Benzyl-4,5-di-O-methylhiascat

Benzyl-4,5-di-O-methylhiascat

C33H30O11 (602.1788)


   

dermocanarin 8

dermocanarin 8

C33H30O11 (602.1788)


   
   

Picrotoxin

3,6-Methano-8H-1,5,7-trioxacyclopenta(ij)cycloprop(a)azulene-4,8(3H)-dione, hexahydro-2a-hydroxy-9-(1-hydroxy-1-methylethyl)-8b-methyl-, (1aR-(1aalpha,2abeta,3beta,6beta,6abeta,8aS*,8bbeta,9S*))-, compd. with (1aR-(1aalpha,2abeta,3beta,6beta,6abeta,8

C15H18O7. C15H16O6 (602.1999)


Cocculus appears as a poisonous berry, the dried fruit of Anamirta cocculus L. Contains several substances including about one percent picrotoxin. Pure picrotoxin occurs as shiny leaflets with an intensely bitter taste or as a microcrystalline powder. Very poisonous!. Used in medicine as a central nervous system stimulant and antidote for barbiturate poisoning. Not currently regarded as a useful therapeutic agent. A mixture of PICROTOXININ and PICROTIN that is a noncompetitive antagonist at GABA-A receptors acting as a convulsant. Picrotoxin blocks the GAMMA-AMINOBUTYRIC ACID-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates. D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D020011 - Protective Agents > D000931 - Antidotes

   

[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

NCGC00385446-01![(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

C29H30O14 (602.1635)


   

Tipranavir

N-{3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3,4-dihydro-2H-pyran-5-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide

C31H33F3N2O5S (602.2062)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

   

Eriodictyol 7-(6-galloylglucoside)

(6-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3,4,5-trihydroxybenzoate

C28H26O15 (602.1272)


   

2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranosyl bromide

2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranosyl bromide

C34H35BrO5 (602.1668)


   

X-Gluc (Dicyclohexylamine)

X-Gluc (Dicyclohexylamine)

C26H36BrClN2O7 (602.1394)


   
   

4-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-1-thiophen-2-ylpyrrolo[3,4-c]pyrrole-3,6-dione

4-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-1-thiophen-2-ylpyrrolo[3,4-c]pyrrole-3,6-dione

C30H39BrN2O2S2 (602.1636)


   

Pigment Red 190

Pigment Red 190

C38H22N2O6 (602.1478)


   

2,4-Hexadiyne-1,6-diol Bis(azobenzene-4-sulfonate)

2,4-Hexadiyne-1,6-diol Bis(azobenzene-4-sulfonate)

C30H26N4O6S2 (602.1294)


   

2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl bromide

2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl bromide

C34H35BrO5 (602.1668)


   

AVE 0991 sodium salt

AVE 0991 sodium salt

C29H31N4NaO5S2 (602.1633)


AVE 0991 sodium salt is a nonpeptide and orally active Ang-(1-7) receptor Mas agonist. AVE 0991 competes for high-affinity binding of [125I]-Ang-(1-7) to bovine aortic endothelial cell membranes with IC50 of 21 nM[1].

   

Ceftazidime t-Butyl Ester

Ceftazidime t-Butyl Ester

C26H30N6O7S2 (602.1617)


   

9,9-Didecyl-2,7-dibromofluorene

9,9-Didecyl-2,7-dibromofluorene

C33H48Br2 (602.2123)


   

14c-Tipranavir

14c-Tipranavir

C31H33F3N2O5S (602.2062)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents

   

{4-[(2S,4E)-2-(1,3-Benzothiazol-2-YL)-2-(1H-1,2,3-benzotriazol-1-YL)-5-phenylpent-4-enyl]phenyl}(difluoro)methylphosphonic acid

{4-[(2S,4E)-2-(1,3-Benzothiazol-2-YL)-2-(1H-1,2,3-benzotriazol-1-YL)-5-phenylpent-4-enyl]phenyl}(difluoro)methylphosphonic acid

C31H25F2N4O3PS (602.1353)


   

(2S)-eriodictyol 7-O-(6-O-galloyl)-beta-D-glucopyranoside

(2S)-eriodictyol 7-O-(6-O-galloyl)-beta-D-glucopyranoside

C28H26O15 (602.1272)


A monosaccharide derivative that is eriodictyol attached to a (6-O-galloyl)-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage.

   
   

7-[4-[(2E)-2-(4-chlorophenyl)-2-(pyridine-4-carbonylhydrazinylidene)ethyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

7-[4-[(2E)-2-(4-chlorophenyl)-2-(pyridine-4-carbonylhydrazinylidene)ethyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

C31H28ClFN6O4 (602.1844)


   

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H33Cl2FN4O4 (602.1863)


   

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H33Cl2FN4O4 (602.1863)


   

1-(2s,3r,4r,5s,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl 6-(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1,6-dicarboxylate

1-(2s,3r,4r,5s,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl 6-(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1,6-dicarboxylate

C28H30N2O13 (602.1748)


   

(13r,23r)-13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone

(13r,23r)-13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone

C33H30O11 (602.1788)


   

4-[(2-carboxyacetyl)oxy]-3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid

4-[(2-carboxyacetyl)oxy]-3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid

C28H26O15 (602.1272)


   

6'-o-p-hydroxybenzoylcatalposide

NA

C29H30O14 (602.1635)


{"Ingredient_id": "HBIN012712","Ingredient_name": "6'-o-p-hydroxybenzoylcatalposide","Alias": "NA","Ingredient_formula": "C29H30O14","Ingredient_Smile": "C1=COC(C2C1C(C3C2(O3)CO)OC(=O)C4=CC=C(C=C4)O)OC5C(C(C(C(O5)COC(=O)C6=CC=C(C=C6)O)O)O)O","Ingredient_weight": "602.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9820","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706008","DrugBank_id": "NA"}

   

(6r,7r,8r)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone

(6r,7r,8r)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)


   

2-({4-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl}oxy)butane-1,2,4-tricarboxylic acid

2-({4-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl}oxy)butane-1,2,4-tricarboxylic acid

C22H34O19 (602.1694)


   

(1s,3r,4s,5r)-4-[(2-carboxyacetyl)oxy]-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid

(1s,3r,4s,5r)-4-[(2-carboxyacetyl)oxy]-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid

C28H26O15 (602.1272)


   

2-(hydroxymethyl)-10-({3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl}oxy)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate

2-(hydroxymethyl)-10-({3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl}oxy)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate

C29H30O14 (602.1635)


   

(6r,7s,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone

(6r,7s,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)


   

(6s,7s,8s)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone

(6s,7s,8s)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)


   

13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone

13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone

C33H30O11 (602.1788)


   

2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate

2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate

C29H30O14 (602.1635)


   

(1s,3r,4s,5r)-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid

(1s,3r,4s,5r)-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid

C28H26O15 (602.1272)


   

(6'r,7'r,8'r)-2,4',6',7',8,8'-hexahydroxy-2',6-dimethoxy-3,7'-dimethyl-6',8'-dihydro-5'h-[1,1'-bianthracene]-9,9',10,10'-tetrone

(6'r,7'r,8'r)-2,4',6',7',8,8'-hexahydroxy-2',6-dimethoxy-3,7'-dimethyl-6',8'-dihydro-5'h-[1,1'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)


   

4-[(2s,5r)-9'-[(3,3-dimethyloxiran-2-yl)methoxy]-4'-methoxy-4,4-dimethylspiro[1,3-dioxolane-2,7'-furo[3,2-g]chromen]-5-ylmethoxy]furo[3,2-g]chromen-7-one

4-[(2s,5r)-9'-[(3,3-dimethyloxiran-2-yl)methoxy]-4'-methoxy-4,4-dimethylspiro[1,3-dioxolane-2,7'-furo[3,2-g]chromen]-5-ylmethoxy]furo[3,2-g]chromen-7-one

C33H30O11 (602.1788)


   

1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone

1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)


   

(13s,23r)-13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone

(13s,23r)-13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone

C33H30O11 (602.1788)


   

8-{9,10-dihydroxy-5,7-dimethoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-9,10-dihydroxy-5,7-dimethoxy-3-methylbenzo[g]isochromen-1-one

8-{9,10-dihydroxy-5,7-dimethoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-9,10-dihydroxy-5,7-dimethoxy-3-methylbenzo[g]isochromen-1-one

C32H26O12 (602.1424)


   

[(2r,3s,4s,5r,6s)-6-{[(2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6s)-6-{[(2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C28H26O15 (602.1272)


   

(2s,3r)-1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate

(2s,3r)-1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate

C32H26O12 (602.1424)


   

4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone

4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)


   

4,6-bis[2-(dimethylamino)ethyl]-1,2,8,9-tetramethoxy-3,7-bis(methylsulfanyl)thianthrene-5,10-diium-5,10-bis(olate)

4,6-bis[2-(dimethylamino)ethyl]-1,2,8,9-tetramethoxy-3,7-bis(methylsulfanyl)thianthrene-5,10-diium-5,10-bis(olate)

C26H38N2O6S4 (602.1613)


   

1-[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl] 6-(3,4,5-trihydroxy-6-methyloxan-2-yl) phenazine-1,6-dicarboxylate

1-[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl] 6-(3,4,5-trihydroxy-6-methyloxan-2-yl) phenazine-1,6-dicarboxylate

C28H30N2O13 (602.1748)


   

(2-{15-[2-(dimethylamino)ethyl]-6,7,12,13-tetramethoxy-5,14-bis(methylsulfanyl)-2,9,10-trithiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-4-yl}ethyl)dimethylamine

(2-{15-[2-(dimethylamino)ethyl]-6,7,12,13-tetramethoxy-5,14-bis(methylsulfanyl)-2,9,10-trithiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-4-yl}ethyl)dimethylamine

C26H38N2O4S5 (602.1435)


   

(2s)-2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid

(2s)-2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid

C22H34O19 (602.1694)


   

1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate

1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate

C32H26O12 (602.1424)


   

13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone

13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone

C33H30O11 (602.1788)


   

3-[(1s,3s,4r,5r)-3,4-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,5-dihydroxycyclohexanecarbonyloxy]-3-oxopropanoic acid

3-[(1s,3s,4r,5r)-3,4-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,5-dihydroxycyclohexanecarbonyloxy]-3-oxopropanoic acid

C28H26O15 (602.1272)


   

(5'r,6'r,7'r)-1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone

(5'r,6'r,7'r)-1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)


   

2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid

2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid

C22H34O19 (602.1694)


   

3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid

3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid

C28H26O15 (602.1272)


   

(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate

(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate

C29H30O14 (602.1635)


   

(2s,3r,4s,5s,6r)-2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate

(2s,3r,4s,5s,6r)-2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate

C29H30O14 (602.1635)


   

(6r,7r,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone

(6r,7r,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)


   

4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone

4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone

C32H26O12 (602.1424)